| Differential expression of selected histone modifier genes in human solid cancers H Özdağ, AE Teschendorff, AA Ahmed, SJ Hyland, C Blenkiron, L Bobrow, ... BMC genomics 7, 1-15, 2006 | 326 | 2006 |
| Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway S Hayami, M Yoshimatsu, A Veerakumarasivam, M Unoki, Y Iwai, ... Molecular cancer 9, 1-14, 2010 | 236 | 2010 |
| Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma MJ Wallard, CJ Pennington, A Veerakumarasivam, G Burtt, IG Mills, ... British journal of cancer 94 (4), 569-577, 2006 | 107 | 2006 |
| Calreticulin and cancer M Zamanian, A Veerakumarasivam, S Abdullah, R Rosli Pathology & Oncology Research 19, 149-154, 2013 | 105 | 2013 |
| Synthesis, characterization and biological evaluation of transition metal complexes derived from N, S bidentate ligands EN Md Yusof, TBSA Ravoof, ERT Tiekink, A Veerakumarasivam, ... International Journal of Molecular Sciences 16 (5), 11034-11054, 2015 | 77 | 2015 |
| Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer AA Aitchison, A Veerakumarasivam, M Vias, R Kumar, FC Hamdy, ... The Prostate 68 (6), 661-674, 2008 | 73 | 2008 |
| Advancements in reprogramming strategies for the generation of induced pluripotent stem cells MI Lai, WY Wendy-Yeo, R Ramasamy, N Nordin, R Rosli, ... Journal of assisted reproduction and genetics 28, 291-301, 2011 | 58 | 2011 |
| Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways M Zamanian, LA Qader Hamadneh, A Veerakumarasivam, ... Cancer cell international 16, 1-13, 2016 | 57 | 2016 |
| A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH N Wicker, A Carles, IG Mills, M Wolf, A Veerakumarasivam, H Edgren, ... BMC genomics 8, 1-10, 2007 | 55 | 2007 |
| Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder … AF Aldoghachi, YS Tor, SZ Redzun, KAB Lokman, NAA Razaq, ... PLoS One 14 (1), e0211241, 2019 | 51 | 2019 |
| Mixed-ligand metal complexes containing an ONS Schiff base and imidazole/benzimidazole ligands: synthesis, characterization, crystallography and biological activity NA Mazlan, TBSA Ravoof, ERT Tiekink, MIM Tahir, A Veerakumarasivam, ... Transition Metal Chemistry 39, 633-639, 2014 | 44 | 2014 |
| High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53 A Veerakumarasivam, HE Scott, SF Chin, A Warren, MJ Wallard, ... Clinical Cancer Research 14 (9), 2527-2534, 2008 | 42 | 2008 |
| Synthesis, characterisation and biological studies of mixed-ligand nickel (II) complexes containing imidazole derivatives and thiosemicarbazide Schiff bases NNM Ishak, J Jamsari, AZ Ismail, MIM Tahir, ERT Tiekink, ... Journal of Molecular Structure 1198, 126888, 2019 | 41 | 2019 |
| MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3 K Saeb-Parsy, A Veerakumarasivam, MJ Wallard, N Thorne, Y Kawano, ... British journal of cancer 99 (4), 663-669, 2008 | 41 | 2008 |
| o-Vanillin Derived Schiff Bases and Their Organotin(IV) Compounds: Synthesis, Structural Characterisation, In-Silico Studies and Cytotoxicity EN Md Yusof, MA M. Latif, MI M. Tahir, JA Sakoff, MI Simone, AJ Page, ... International journal of molecular sciences 20 (4), 854, 2019 | 39 | 2019 |
| A role for neurotensin in bicalutamide resistant prostate cancer cells M Vias, G Burtt, Z Culig, A Veerakumarasivam, DE Neal, IG Mills The Prostate 67 (2), 190-202, 2007 | 39 | 2007 |
| Molecular pathways governing development of vascular endothelial cells from ES/iPS cells KS Tan, K Tamura, MI Lai, A Veerakumarasivam, Y Nakanishi, M Ogawa, ... Stem Cell Reviews and Reports 9, 586-598, 2013 | 38 | 2013 |
| Evaluation of a recombinant Newcastle disease virus expressing human IL12 against human breast cancer Z Mohamed Amin, MA Che Ani, SW Tan, SK Yeap, NB Alitheen, ... Scientific Reports 9 (1), 13999, 2019 | 37 | 2019 |
| Dynamics of PEGylated–dextran–spermine nanoparticles for gene delivery to leukemic cells R Amini, FA Jalilian, S Abdullah, A Veerakumarasivam, H Hosseinkhani, ... Applied biochemistry and biotechnology 170, 841-853, 2013 | 34 | 2013 |
| Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle‐invasive bladder cancer PMS Gurung, A Veerakumarasivam, M Williamson, N Counsell, J Douglas, ... International Journal of Cancer 136 (3), 709-720, 2015 | 29 | 2015 |
John D KellyProfessor of Uro-oncology, UCL在 UCL.AC.UK 的电子邮件经过验证
